While investments in biomedical R&D have led to tremendous scientific breakthroughs and health improvements in the modern era, the benefits have been shared unevenly.

An estimated two billion people lack the medicines they need. The 2016 Access to Medicines Index analyzes pharmaceutical companies’ efforts to improve access to medicines, vaccines and diagnostics for low- and middle-income countries.